Synergy CHC Corp. Common Stock

SNYR

Synergy CHC Corp. is a healthcare company focused on providing comprehensive home healthcare and hospice services. It operates through a network of agencies that deliver supportive and end-of-life care, emphasizing patient-centered approaches. The company aims to improve quality of life for patients by offering services in their own homes and community settings.

$0.19 -0.01 (-6.45%)
🚫 Synergy CHC Corp. Common Stock does not pay dividends

Company News

Synergy CHC Shares Surge Nearly 100% In After-Hours Trading: What's Going On?
Benzinga • Tanya Rawat • April 14, 2026

Synergy CHC Corp. (NASDAQ:SNYR) shares surged nearly 100% in after-hours trading following an S-8 filing to register approximately 2.25 million shares under its 2024 Equity Incentive Plan. The stock jumped from $0.58 to approximately $1.15, though the company has declined sharply over the past year, falling nearly 68%, and exhibits a negative pri...

Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options
GlobeNewswire Inc. • Not Specified • December 27, 2025

SynergyRx, a telehealth platform, offers compounded semaglutide starting at $200/month and oral tablet alternatives for weight loss medication. The platform maintains LegitScript certification and publishes provider credentials, but compounded medications lack FDA approval as finished products. The article emphasizes regulatory scrutiny in the GL...

Alkane Resources Limited: Appointment of Non-Executive Director
GlobeNewswire Inc. • Nic Earner (Managing Director & Ceo) • November 24, 2025

Alkane Resources Limited has appointed Denise McComish as an independent Non-Executive Director, effective December 1, 2025. Ms. McComish brings extensive financial, strategy, and board experience, including 30 years as a KPMG partner.

Synergy CHC Corp. Announces Pricing of $4.375 Million Public Offering
GlobeNewswire Inc. • Synergy Chc Corp • August 26, 2025

Synergy CHC Corp is conducting a public offering of 1,750,000 shares at $2.50 per share, raising $4.375 million for working capital and general corporate purposes, with additional option for underwriters to purchase 262,500 more shares.

Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability
GlobeNewswire Inc. • Jack Ross (Ceo) • August 14, 2025

Synergy CHC Corp reported its tenth consecutive quarter of profitability, with revenue of $8.1 million, a gross margin of 76.7%, and net income of $1.5 million. The company expanded its FOCUSfactor brand internationally and secured new North American retail distribution partnerships.

Related Companies